Some follow the noise.

Bloomberg follows the money, whether it's the funds fueling AI or crypto's trillion

dollar swings. There's a money side to every story. Get the money side of the story.

Subscribe now at Bloomberg.com.

Changes in sexual performance are more common than most people realise, and support doesn't need to feel awkward.

With MedExpress, everything happens privately online.

Start by completing a short consultation reviewed by UK registered clinicians.

If eligible, treatment is delivered discreetly to your home with ongoing support whenever you need it.

You're not alone in this. Visit Medexpress.co.com.uk slash podcast to learn more.

Details of SpaceX's IPO are expected to be made public this week as it accelerates plans

for a stock debut that will likely make CEO Elon Musk of the world's first trillionaire,

but one analyst warned that trading may be volatile as the stock faces substantial downside risks.

SpaceX, which filed confidential initial public offering registration with the Securities

and Exchange Commission in April will likely

make public its paperwork, offering insight into the firm's operations and finances this

week as it plans for a June 12 debut on the NASDAQ, the Wall Street Journal reported, citing

people familiar with the matter. Some have expressed concerns about SpaceX's stock listing, including pitchbook analyst Franco

Granda, who wrote in March that SpaceX may act like Tesla's stock on steroids suggesting

trading volatility.

Jay Ritter, a finance professor at the University of Florida and director of its market

research program, the IPO initiative, told Forbes the, quote, Elon Musk effect is likely

to influence SpaceX's stock, boosting demand for the IPO while adding long-term volatility

...